Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives
Authors:
Open Access
- 11 December 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11961
Abstract
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive cancer arising within the liver from the bile ducts, and it is characterized by limited therapeutic options and a poor prognosis. This neoplasm exhibits both high intra-tumor and inter-tumor heterogeneity and many oncogenic and tumor suppressor genes are involved in its development and progression. Here, we summarize the major pathways and driver genes involved in the genesis and progression of iCCA, with a special look at their potential therapeutic values. We approach not only the well–known FGFR, IDH and HER2 alterations but also delve into less known cellular pathways such as cell surface receptors, cellular signaling pathways, tumor suppressor genes and metabolic pathways. The aim of our review is therefore not only to summarize the available evidence on singular pathways/alterations but also to foster and promote new investigations into lesser known alterations that could be present in each singular iCCA case.Keywords
This publication has 265 references indexed in Scilit:
- Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancersCancer, 2020
- A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinomaCancer, 2017
- Biliary cancer: Utility of next‐generation sequencing for clinical managementCancer, 2016
- Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk areaGenes, Chromosomes and Cancer, 2014
- Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2Hepatology, 2014
- Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinomaHepatology, 2012
- Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cellsHepatology, 2010
- Notch2 signaling promotes biliary epithelial cell fate specification and tubulogenesis during bile duct development in mice #Hepatology, 2009
- Blocking the hedgehog pathway inhibits hepatoblastoma growth #Hepatology, 2009
- Rare PIK3CA hotspot mutations in carcinomas of the biliary tractGenes, Chromosomes and Cancer, 2008